Sandra Patterson's Insider Trades & SAST Disclosures
Sandra Patterson's most recent trade in Gilead Sciences, Inc. was a trade of 1,952 Restricted Stock Unit done . Disclosure was reported to the exchange on March 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sandra Patterson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,952 | 9,875 | - | - | Restricted Stock Unit | |
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,952 | 40,077 (0%) | 0% | - | Common Stock | |
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.21 per share. | 10 Mar 2025 | 624 | 39,453 (0%) | 0% | 117.2 | 73,139 | Common Stock |
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 709 | 37,787 (0%) | 0% | 0 | Common Stock | |
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Dec 2024 | 901 | 12,282 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Dec 2024 | 901 | 37,486 (0%) | 0% | - | Common Stock | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Dec 2024 | 408 | 37,078 (0%) | 0% | 92.3 | 37,675 | Common Stock | |
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Sep 2024 | 901 | 13,183 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Sep 2024 | 901 | 36,877 (0%) | 0% | - | Common Stock | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Sep 2024 | 292 | 36,585 (0%) | 0% | 81.4 | 23,780 | Common Stock | |
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Aug 2024 | 3,678 | 14,084 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Aug 2024 | 3,678 | 36,956 (0%) | 0% | - | Common Stock | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Aug 2024 | 980 | 35,976 (0%) | 0% | 73.7 | 72,187 | Common Stock | |
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Jun 2024 | 901 | 17,762 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Jun 2024 | 901 | 33,533 (0%) | 0% | - | Common Stock | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Jun 2024 | 255 | 33,278 (0%) | 0% | 65.3 | 16,639 | Common Stock | |
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Mar 2024 | 13,660 | 13,660 | - | - | Non-qualified Stock Option (Right to Buy) | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Mar 2024 | 4,825 | 18,663 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Mar 2024 | 1,934 | 33,422 (0%) | 0% | - | Common Stock | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Mar 2024 | 1,934 | 13,838 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Mar 2024 | 790 | 32,632 (0%) | 0% | 75.1 | 59,345 | Common Stock | |
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Mar 2024 | 748 | 31,488 (0%) | 0% | - | Common Stock | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Mar 2024 | 748 | 15,772 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 13 Dec 2023 | 298 | 37,235 (0%) | 0% | 83.1 | 24,761 | Common Stock | |
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 13 Dec 2023 | 181 | 37,259 (0%) | 0% | - | Common Stock | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 13 Dec 2023 | 181 | 12,101 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 13 Dec 2023 | 157 | 11,827 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 13 Dec 2023 | 157 | 37,078 (0%) | 0% | 91.9 | 14,421 | Common Stock | |
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 13 Dec 2023 | 157 | 37,533 (0%) | 0% | - | Common Stock | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 13 Dec 2023 | 117 | 37,376 (0%) | 0% | - | Common Stock | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 13 Dec 2023 | 117 | 11,984 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Dec 2023 | 518 | 16,520 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Dec 2023 | 518 | 30,642 (0%) | 0% | - | Common Stock | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Dec 2023 | 222 | 30,420 (0%) | 0% | 79.0 | 17,542 | Common Stock | |
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Sep 2023 | 519 | 17,038 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Sep 2023 | 519 | 30,273 (0%) | 0% | - | Common Stock | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Sep 2023 | 149 | 30,124 (0%) | 0% | 76 | 11,324 | Common Stock | |
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Aug 2023 | 4,484 | 31,060 (0%) | 0% | - | Common Stock | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Aug 2023 | 4,484 | 17,557 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Aug 2023 | 1,306 | 29,754 (0%) | 0% | 80 | 104,480 | Common Stock | |
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Jun 2023 | 517 | 22,041 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Jun 2023 | 517 | 26,729 (0%) | 0% | - | Common Stock | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Jun 2023 | 153 | 26,576 (0%) | 0% | 78.1 | 11,952 | Common Stock | |
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Mar 2023 | 10,405 | 10,405 | - | - | Non-qualified Stock Option (Right to Buy) | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Mar 2023 | 6,130 | 22,558 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Mar 2023 | 1,601 | 17,748 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Mar 2023 | 1,601 | 25,693 (0%) | 0% | - | Common Stock | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Mar 2023 | 1,320 | 16,428 | - | - | Restricted Stock Unit | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Mar 2023 | 1,320 | 27,013 (0%) | 0% | - | Common Stock | ||
| Gilead Sciences, Inc. | Sandra Patterson | SVP, Controllership | 10 Mar 2023 | 801 | 26,212 (0%) | 0% | 79.5 | 63,680 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges